Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Qiongya WU"'
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Lung cancer is the leading cause of cancer death globally, killing 1.8 million people yearly. Over 85% of lung cancer cases are non-small cell lung cancer (NSCLC). Lung cancer running in families has shown that some genes are linked to lung cancer. G
Externí odkaz:
https://doaj.org/article/4950c21ab2b84120bdee1edad2f8ba35
Autor:
Ziyang Zhou, Xiao Song, Ailu Wu, Hui Liu, Hongyu Wu, Qiongya Wu, Yu Liu, Yefei Li, Yong Cai, Shixiong Liang
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
Abstract Pulmonary emphysema (PE) has been demonstrated to have a high prevalence in patients with locally advanced non-small cell lung cancer (NSCLC). A total of 153 patients with locally advanced NSCLC were enrolled in this study to investigate the
Externí odkaz:
https://doaj.org/article/7141872cf7e04581a9c7145b112e1d5a
Publikováno v:
Chinese Journal of Lung Cancer, Vol 14, Iss 9, Pp 719-722 (2011)
Background and objective Brain metastases are a common complication of lung cancer, occurring in 20%-40% of patients. The aim of this study is to explore prognostic factors in non-small cell lung cancer (NSCLC) in patients with brain metastases diagn
Externí odkaz:
https://doaj.org/article/b3f4d5714584485893ee21e51d8fdd9c
Publikováno v:
International journal of immunopathology and pharmacology. 36
Background Lung cancer has the fastest increase in morbidity and mortality, and is one of the most threatening malignant tumors to human health and life. Both radiotherapy and targeted therapy are typical treatments after lung cancer surgery. Radioth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::007dc1ccaeb4dbacdcff25c8120dae3e
https://pubmed.ncbi.nlm.nih.gov/36172813
https://pubmed.ncbi.nlm.nih.gov/36172813
Publikováno v:
OncoTargets and Therapy. 13:9667-9678
Background Emerging researches have demonstrated that aberrantly expressed long non-coding RNAs (lncRNAs) have great significance in non-small cell lung cancer (NSCLC) progression. The aim of this study was to explore the role of lncRNA AZIN1 antisen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8b8da7adf1f72279ac0a2dba55e8a38
https://doi.org/10.2147/ott.s261497
https://doi.org/10.2147/ott.s261497
Autor:
Leilei Wu, Yaoyao Zhu, Xiaoshuai Yuan, Yu Liu, Qiongya Wu, Qinghua Xu, Min Hu, Jingjing Kang, Jiamei Fu, Xiaomei Gong, Hongyu Wu, Yong Cai, Lixin Wang, Yi Lu, Yan Li, Hui Liu, Yaping Xu
Publikováno v:
Annals of Translational Medicine. 10:800-800
Traditional Chinese medicine (TCM) makes a synergistic and attenuative effect when combined with chemoradiotherapy. However, strong evidence-based studies are lacking. The study sought to investigate whether Zengxiao Jiandu decoction as an adjunctive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0f2d49b286370f564399e90a272fc26
https://doi.org/10.21037/atm-22-2814
https://doi.org/10.21037/atm-22-2814
Publikováno v:
Archives of Virology. 162:2923-2936
White spot syndrome virus (WSSV) has been extensively investigated since the white spot disease outbreak in shrimp in 1990. These investigations have mainly focused on determining the function of viral structural proteins, and on utilizing the envelo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac170793680d86b08b25c2bcc0526e53
https://doi.org/10.1007/s00705-017-3450-x
https://doi.org/10.1007/s00705-017-3450-x
Autor:
Chengliang Yang, Aihua Shu, Mi Zhou, Chen Xiaobo, Chenhong Huang, Leyun Zhan, Yulin Zhang, Yaojun Tan, Qiongya Wu, Bingyi Zhang
Publikováno v:
Medicine
Supplemental Digital Content is available in the text
Background: Methylation of the Ras-association domain family 1 isoform A (RASSF1A) gene promoter region is thought to participate in the initiation and development of many different cancers.
Background: Methylation of the Ras-association domain family 1 isoform A (RASSF1A) gene promoter region is thought to participate in the initiation and development of many different cancers.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f69f1c124a896e189d9a6fe02aea964
https://doi.org/10.1097/md.0000000000006097
https://doi.org/10.1097/md.0000000000006097
Publikováno v:
Zhongguo fei ai za zhi = Chinese journal of lung cancer. 5(6)
To evaluate the therapeutic effect and acute side-effect of escalated hyperfractionated accelerated radiation therapy (EHART) combined with chemotherapy for stage IIIB non-small cell lung cancer (NSCLC).From Aug. 1998 to Aug. 2001, a prospective tria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::91aca41554b3f78e14f81d3c24fd57c3
https://pubmed.ncbi.nlm.nih.gov/21333220
https://pubmed.ncbi.nlm.nih.gov/21333220
Publikováno v:
Zhongguo fei ai za zhi = Chinese journal of lung cancer. 9(3)
Concurrent chemotherapy plus radiotherapy is a trend in treatment of non-small cell lung cancer (NSCLC), but the treatment program is rather complicated and the toxicity is more severe than chemotherapy or radiotherapy alone. The aim of this study is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a44ff506ffb89cecce900682077d6012
https://pubmed.ncbi.nlm.nih.gov/21172164
https://pubmed.ncbi.nlm.nih.gov/21172164